Dashboard
1
Poor Management Efficiency with a low ROE of 9.50%
- The company has been able to generate a Return on Equity (avg) of 9.50% signifying low profitability per unit of shareholders funds
2
Weak Long Term Fundamental Strength with an average Return on Equity (ROE) of 9.50%
3
Flat results in Jun 25
4
With ROE of 1.80%, it has a Very Expensive valuation with a 1.46 Price to Book Value
5
Consistent Underperformance against the benchmark over the last 3 years
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-18.92%
0%
-18.92%
6 Months
-26.3%
0%
-26.3%
1 Year
-39.11%
0%
-39.11%
2 Years
-60.52%
0%
-60.52%
3 Years
-69.7%
0%
-69.7%
4 Years
-76.46%
0%
-76.46%
5 Years
-68.74%
0%
-68.74%
Tecan Group AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.86%
EBIT Growth (5y)
-4.56%
EBIT to Interest (avg)
66.56
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
0.71
Tax Ratio
13.56%
Dividend Payout Ratio
56.60%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.44%
ROE (avg)
9.50%
Valuation key factors
Factor
Value
P/E Ratio
81
Industry P/E
Price to Book Value
1.46
EV to EBIT
64.56
EV to EBITDA
64.56
EV to Capital Employed
1.52
EV to Sales
8.42
PEG Ratio
NA
Dividend Yield
2.06%
ROCE (Latest)
2.35%
ROE (Latest)
1.80%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'06 - YoY
Dec'06
Dec'05
Change(%)
Net Sales
110.40
108.30
1.94%
Operating Profit (PBDIT) excl Other Income
15.80
11.90
32.77%
Interest
1.20
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
14.40
7.60
89.47%
Operating Profit Margin (Excl OI)
143.50%
109.60%
3.39%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2006 is 1.94% vs 0.00% in Dec 2005
Consolidated Net Profit
YoY Growth in quarter ended Dec 2006 is 89.47% vs 0.00% in Dec 2005
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
1,074.40
1,144.30
-6.11%
Operating Profit (PBDIT) excl Other Income
201.70
213.00
-5.31%
Interest
1.00
1.30
-23.08%
Exceptional Items
4.80
-2.50
292.00%
Consolidate Net Profit
132.10
121.10
9.08%
Operating Profit Margin (Excl OI)
121.80%
127.60%
-0.58%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is -6.11% vs 20.89% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 9.08% vs -0.49% in Dec 2022
About Tecan Group AG 
Tecan Group AG
Pharmaceuticals & Biotechnology
Tecan Group AG is a Switzerland-based company engaged in the development, production and distribution of advanced automation and detection solutions for the life science laboratories. Its product portfolio is diversified into several product groups. The Liquid Handling & Robotics group encompasses laboratory technologies for safety, among others. The Reader & Washer product group covers micro plate instruments. The Microarray Products group includes microarray scanner and automated hybridization station. The HP D300 Digital Dispenser and Sample Management product groups cover systems for automated management of sample libraries. The Components group covers the supply services of products for laboratory automation instruments. The OEM (original equipment manufacturing) product group covers platform-based systems, systems from scratch and Cavro OEM Components. The Company also offers packaged software and consumables through Software and Consumables product groups, respectively.
Company Coordinates 
Company Details
Seestrasse 103 , MAENNEDORF None : 8708
Registrar Details






